NASDAQ · IXHL
Incannex Healthcare Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for IXHL: Nov 13, 2026
Incannex Healthcare Inc. Common Stock is estimated to report earnings on 11/13/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 1 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.66. The reported EPS for the same quarter last year was $-0.6.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-0.66 | $-0.66 | $-0.66 | 1 |
| Dec 2026 | $-0.66 | $-0.66 | $-0.66 | 1 |
| Mar 2027 | $-0.66 | $-0.66 | $-0.66 | 1 |
| Jun 2027 | $-0.66 | $-0.66 | $-0.66 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · Zacks · Quiver Quantitative- RTTNews · Jun 8, 10:41 PM EDTTop Biotech Gainers: TNGX Hits New High, ALVO Moves Closer To FDA Approval, ZVRA, IDYA Turn Heads(RTTNews) – Today's top gainers include Tango Therapeutics, following encouraging pancreatic cancer trial data; Aspire Biopharma, ahead of upcoming milestones; Alvotech, after FDA acceptance of its interchangeable biosimilar to Entyvio for review; and Zevra Therapeutics, on actio
- RTTNews · Mar 12, 9:46 AM EDTIncannex Healthcare Stock Falls 35% Over Announcement Of IHL-42X Development Plan, Stock Offering(RTTNews) – Shares of Incannex Healthcare Inc. (IXHL) are falling about 35 percent on Thursday morning trading following the announcement of an enhanced clinical development strategy for IHL-42X, its lead oral drug candidate for the treatment of obstructive sleep apnea, and a sec
- RTTNews · Mar 12, 9:30 AM EDTIncannex Healthcare Prices $10 Mln Potential Offering Of Shares And Warrants; Stock Down(RTTNews) – Incannex Healthcare Inc. (IXHL), a clinical-stage biopharmaceutical company, announced that it has entered into a securities purchase agreement with healthcare-dedicated institutional investors for the issuance and sale of 2 million shares and accompanying warrants to
- RTTNews · Dec 3, 8:36 AM ESTWhy Incannex Is Rising In Pre-market?(RTTNews) – Incannex Healthcare (IXHL) announced that the FDA has granted Fast Track designation for IHL-42X, the company's oral fixed-dose combination product candidate for the treatment of obstructive sleep apnea. The Fast Track designation was supported by safety, efficacy,
- Zacks · Dec 1, 12:00 PM ESTWhat Makes Incannex Healthcare Inc. (IXHL) a New Buy StockIncannex Healthcare Inc. (IXHL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
- RTTNews · Oct 2, 1:09 AM EDTZCMD, ABCL, VOR, IXHL, OVID, BFRG Rally After Hours On Clinical Momentum And Recent Updates(RTTNews) – Several biotech and healthcare stocks posted notable after-hours gains on Wednesday, October 1, with price action largely driven by technical momentum and recent clinical updates rather than fresh disclosures. While most companies did not issue new filings or press re
- RTTNews · Aug 22, 8:58 AM EDTIncannex Healthcare To Repurchase Up To $20 Million In Shares; Stock Up In Pre-market(RTTNews) – Incannex Healthcare Inc. (IXHL), a clinical-stage biopharmaceutical company, on Friday announced that its board has approved a share repurchase program of up to $20 million of its outstanding common stock.
- Quiver Quantitative · Jun 24, 7:42 AM EDTIncannex Healthcare Appoints Dr. Douglas B. Kirsch to IHL-42X Obstructive Sleep Apnea Clinical Advisory BoardIncannex Healthcare appoints Dr. Douglas B. Kirsch to its IHL-42X Obstructive Sleep Apnea Clinical Advisory Board.
- Quiver Quantitative · Jun 17, 7:41 AM EDTIncannex Healthcare Inc. Forms Joint Venture with Mind Medicine Australia for Psychedelic-Assisted Therapy Clinic in MelbourneIncannex forms a joint venture with Mind Medicine Australia to launch a psychedelic-assisted therapy clinic in Melbourne.
- Quiver Quantitative · Jun 12, 7:42 AM EDTIncannex Healthcare Inc. Completes Cancellation of Series A Warrants to Enhance Capital StructureIncannex Healthcare cancels Series A Warrants, eliminating 347.2 million shares from future dilution ahead of key clinical trial data.
- Quiver Quantitative · Jun 3, 7:41 AM EDTIncannex Healthcare Inc. Appoints Four Experts to IHL-42X Obstructive Sleep Apnea Clinical Advisory BoardIncannex Healthcare appoints four experts to its Clinical Advisory Board for developing IHL-42X, targeting obstructive sleep apnea.
- Quiver Quantitative · May 28, 7:12 AM EDTIncannex Healthcare Inc. Finalizes Agreement to Cancel Remaining Series A Warrants, Reducing Potential Dilution by Up to 347.2 Million SharesIncannex Healthcare cancels 172 million Series A Warrants, reducing potential share dilution and strengthening capital structure ahead of key trial data.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Incannex Healthcare Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.